ConvaTec Group (LON:CTEC) Earns “Buy” Rating from Berenberg Bank

ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating reiterated by Berenberg Bank in a research note issued to investors on Wednesday, MarketBeat reports. They currently have a GBX 310 ($3.99) price target on the stock. Berenberg Bank’s price target indicates a potential upside of 16.02% from the stock’s previous close.

ConvaTec Group Trading Down 0.8 %

Shares of CTEC stock opened at GBX 267.20 ($3.44) on Wednesday. The company has a market capitalization of £6.79 billion, a PE ratio of 45.00, a price-to-earnings-growth ratio of 0.93 and a beta of 0.64. ConvaTec Group has a 52-week low of GBX 211.80 ($2.73) and a 52-week high of GBX 295.20 ($3.80). The business’s fifty day moving average is GBX 239.15 and its 200 day moving average is GBX 232.91. The company has a debt-to-equity ratio of 85.32, a quick ratio of 0.96 and a current ratio of 2.26.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.